Tekmira Provides Corporate Update and Announces Third Quarter 2012 Results

[at noodls] – VANCOUVER, British Columbia, Nov. 13, 2012 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today … more

View todays social media effects on TKMR

View the latest stocks trending across Twitter. Click to view dashboard